New meta-analysis with Diamyd® published in scientific journal

An update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes vaccine Diamyd[®][ ]in individuals recently diagnosed with Type 1 Diabetes carrying the genetic HLA DR3-DQ2 haplotype has been published in the peer-reviewd scientific journal Diabetes, Obesity and Metabolism. The analysis shows that treatment effect with Diamyd[®] on the preservation of endogenous insulin production measured as C-peptide is associated with a beneficial treatment effect on blood glucose measured as HbA1c.“To our knowledge, this is the first analysis that shows a clear association